Detalles de la búsqueda
1.
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients.
Ann Surg Oncol;
30(4): 2377-2388, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36752970
2.
Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma.
Int J Cancer;
150(11): 1870-1878, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35001363
3.
Automated synthesis of 68 Ga/177 Lu-PSMA on the Trasis miniAllinOne.
J Labelled Comp Radiopharm;
63(8): 393-403, 2020 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32374450
4.
ASO Visual Abstract: Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma-A National Cohort Study of 1480 Patients.
Ann Surg Oncol;
30(4): 2389-2390, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715857
5.
Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP.
Acta Oncol;
56(7): 909-916, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28438067
6.
Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Acta Oncol;
55(9-10): 1175-1182, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27548393
7.
Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbidities.
Acta Oncol;
59(7): 793-796, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32285728
8.
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression.
Cancers (Basel);
16(5)2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473325
9.
Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy.
Radiol Oncol;
47(4): 358-65, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24294180
10.
Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol.
BMJ Open;
13(1): e063500, 2023 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717150
11.
Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial.
Acta Oncol;
51(6): 713-21, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22731832
12.
Observer variability in a phase II trial - assessing consistency in RECIST application.
Acta Oncol;
51(6): 774-80, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22432439
13.
Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients.
Eur J Surg Oncol;
47(12): 3020-3027, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34120809
14.
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Nat Med;
27(12): 2212-2223, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34887574
15.
The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
Head Neck;
41(2): 329-339, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552847
16.
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study.
Oncoimmunology;
7(12): e1502905, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30524900
17.
Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Nat Med;
28(4): 871, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260843
18.
Routine X-ray of the chest is not justified in staging of cutaneous melanoma patients.
Dan Med J;
63(12)2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27910800
19.
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.
Clin Cancer Res;
22(15): 3734-45, 2016 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27006492
20.
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Cancer Med;
3(5): 1294-301, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24941936